Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases
β Scribed by G. Mentha; S. Terraz; P. Morel; A. Andres; E. Giostra; A. Roth; L. Rubbia-Brandt; P. Majno
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 437 KB
- Volume
- 96
- Category
- Article
- ISSN
- 0007-1323
- DOI
- 10.1002/bjs.6436
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background
Bilobar colorectal metastases are a therapeutic challenge and require a multidisciplinary approach. The aim of this study was to describe the clinical and histological outcomes of patients having neoadjuvant chemotherapy and two-step hepatectomy with right portal vein occlusion for advanced bilateral colorectal metastases.
Methods
A series of 23 consecutive patients treated with curative intent according to a standardized multidisciplinary management protocol was reviewed.
Results
Of 23 patients, 22 completed the programme. There was no mortality and no Clavien grade III morbidity. Median survival from the start of treatment was 45 months, and 1-, 3- and 5-year KaplanβMeier estimates were 95, 73 and 27 per cent respectively. On histology at the first operation, ten patients had a dangerous halo of proliferating tumour cells infiltrating the surrounding liver parenchyma, of variable importance (six focal and four diffuse), regardless of the response to chemotherapy of the metastases. The dangerous halo increased in prevalence and importance (six focal and seven diffuse) between the first and second operation.
Conclusion
Neoadjuvant chemotherapy followed by two-step hepatectomy with right portal vein occlusion is feasible, safe and may be advantageous to the patient. The appearance of a dangerous halo around the liver metastases may require adaptation of the surgical technique to decrease the risk of local recurrence.
π SIMILAR VOLUMES
## Abstract ## Background The results of surgery for recurrent colorectal liver metastases (CLM) after radiofrequency ablation (RFA) have not been evaluated. ## Methods From 1993 to 2009, data on patients who underwent resection or RFA for recurrent CLM were collected prospectively. Inclusion cr
## Abstract ## Background As surgical resection of colorectal liver metastases (CLM) remains the only treatment for cure, efforts to extend the surgical indications to include patients with multiple bilobar CLM have been made. This study evaluated the long-term outcome, safety and efficacy of two-